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In the developing brain, differentiation of neural precursors into
neurons or glial cells occurs in response to neurotrophic factors
acting on the cell surface. Intracellular signaling mechanisms
that relay information to initiate differentiative responses of
neural precursor cells are poorly understood. To investigate
whether stimulation of the cAMP-dependent signaling pathway
participates in differentiative responses of cells in the develop-
ing CNS, we performed experiments using both conditionally
immortalized neural precursor cells (RC2.E10 cells) and primary
cultures of cells from developing rat cortex. Initially, we deter-
mined that RC2.E10 cells retain phenotypic features of neural
precursors after inactivation of the immortalizing oncogene, a
temperature-sensitive mutant of the simian virus 40 large-T
antigen (SV40T). We found that, once SV40T is inactivated,
RC2.E10 cells cease to divide and die. However, RC2.E10 cells
can proliferate in the presence of basic fibroblast growth factor.
In addition, they express nestin, a marker of neural precursor
cells. Both RC2.E10 cells and primary cortical precursor cells
undergo astroglial differentiation in response to cAMP stimula-
tion by treatment with 8-bromo-cAMP. In both cases, cAMP-
induced astrocyte differentiation is characterized by morpho-
logical changes, stimulation of glial fibrillary acidic protein
expression, downregulation of nestin expression, and de-
creased proliferation. No increases in the expression of neuro-
nal or oligodendrocytic markers were observed. Our results
support the notion that the developing CNS contains neural
precursor cells with the capacity of undergoing astrocyte dif-
ferentiation in response to increased intracellular cAMP
concentrations.
Key words: neural precursor cells; astrocyte differentiation;
cortical development; cAMP; conditional immortalization;
GFAP; nestin
During embryonic development, discrete populations of prolifer-
ating progenitor cells in the neural tube respond to signals that
determine their commitment to differentiate into neuronal or
glial lineages (Johe et al., 1996; McKay, 1997). Choices taken by
neural precursors have been investigated with recombinant ret-
roviruses as tracers of cell fates (Halliday and Cepko, 1992; Reid
et al., 1995; Williams and Price, 1995) or by analyzing the fate of
clonal immortalized precursor cell lines engrafted after trans-
plantation into the developing CNS (Renfranz et al., 1991; Snyder
et al., 1992; Vicario-Abejo´n et al., 1995a; Bru¨stle et al., 1997).
However, these studies do not provide information about the
environmental factors to which precursor cells respond or the
intracellular signaling mechanisms that are activated to promote
differentiation.
In recent years a number of factors that govern the differen-
tiative potential of neural precursors have been identified. Among
them, basic fibroblast growth factor (bFGF) is important to main-
tain proliferation (Ray et al., 1993; Gage et al., 1995; Ghosh and
Greenberg, 1995; Vicario-Abejo´n et al., 1995b; Johe et al., 1996;
Cavanagh et al., 1997); ciliary neurotrophic factor (CNTF) and
bone morphogenetic proteins promote the differentiation of as-
trocytes (Rao et al., 1988; Gross et al., 1996; Bonni et al., 1997);
platelet-derived growth factor, neurotrophin-3, and brain-derived
neurotrophic factor induce neuronal differentiation (Ghosh and
Greenberg, 1995; Vicario-Abejo´n et al., 1995b; Johe et al., 1996);
and finally, hormonal activation of certain nuclear receptors leads
to generation of oligodendrocytes (Barres et al., 1994; Johe et al.,
1996).
Phenotypic transitions induced in neural precursor cells by
neurotrophic molecules are the consequence of coordinated
changes in the expression of specific sets of genes. Therefore,
stimulation of intracellular signaling pathways that results in the
rapid activation of transcription factors that relay information to
the nucleus is a likely mechanism by which extracellular factors
induce differentiation (Segal and Greenberg, 1996; Bonni et al.,
1997; Rajan and McKay, 1998). Stimulation of the cAMP-
dependent signaling pathway represents one possible mechanism
for the activation of transcriptional programs that result in phe-
notypic changes during development.
Stimulation of cAMP signaling leads to the activation of pro-
tein kinase A (PKA), which phosphorylates transcription factors
such as cAMP response element-binding protein (CREB) (Mont-
miny, 1997). CREB, which can be phosphorylated also by other
kinases activated by different neurotrophic factors (Ghosh and
Greenberg, 1995; Xing et al., 1996; Finkbeiner et al., 1997; Pende
et al., 1997), has been associated with changes in cellular plasticity
in the adult and developing CNS (Liu and Graybiel, 1996; Moore
et al., 1996; Murphy and Segal, 1997). In addition, cAMP regu-
lates the activity of guanine nucleotide exchange factors that
trigger signaling mechanisms independent of PKA (Kawasaki et
al., 1998). However, it is not known whether activation of cAMP
signaling participates in the differentiative responses of neural
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precursor cells. In the present study, we report on the initiation of
astrocytic differentiation of cultured cortical precursors after
stimulation of the cAMP-dependent signaling pathway.
MATERIALS AND METHODS
Materials. DNA-modifying enzymes were purchased from New England
Biolabs (Beverly, MA), or Promega (Madison, WI). Radioactive com-
pounds were obtained from DuPont New England Nuclear (Boston,
MA). Nucleotides were purchased from Pharmacia (Piscataway, NJ).
Tissue culture medium was prepared by the Cell Culture Core Facility of
the Reproductive Endocrine Sciences Center at Massachusetts General
Hospital, and reagents were obtained from Life Technologies (Grand
Island, NY). All other reagents were obtained from Sigma (St. Louis,
MO) unless otherwise specified.
Plasmids. Construction of expression plasmids encoding the
C-terminal region of nestin was performed with a fragment of nestin
cDNA generated by RT-PCR as follows. Total RNA (10 mg) purified by
CsCl gradient centrifugation from whole brains dissected from embry-
onic day 15 (E15) rats was primed with poly(dT)15 and incubated with
avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim,
Indianapolis, IN) to synthesize cDNA. This was used as a template to
amplify a fragment of cDNA encoding 207 amino acids of the C-terminal
region of nestin (C/Nestin, residues 1599–1805) by PCR, using specific
primers designed from the published sequence of the nestin cDNA
(Lendahl et al., 1990). The sequence of the forward primer is 59-
ACGGATCCGATGGGTTTGCTGATGAG-39, and that of the reverse
primer is 59-CAGAATTCAGCCAGAGGGGCAGTTTC-39. These
primers incorporate BamHI and EcoRI sites at their ends, respectively.
PCR conditions were 95°C for 5 min, followed by 30 cycles of 94°C for 30
sec, 50°C for 30 sec, and 72°C for 1 min, after which a 5 min incubation
at 72°C followed. The PCR product was digested with BamHI and EcoRI
and cloned into the plasmid pGEX-KG (Guan and Dixon, 1991) for
bacterial expression of a fusion protein composed of glutathione
S-transferase (GST) and the C terminus of nestin.
For the construction of a eukaryotic expression plasmid encoding the
C-terminal 207 amino acid fragment of nestin (C/Nestin), a similar PCR
was performed, with the exception that the forward primer was replaced
by another with the following sequence: 59-GCCACCATGGATGGGTT-
TGCTGATGAG-39. The resulting fragment, which encodes nestin resi-
dues 1599–1805 and incorporates an in-frame initiation methionine en-
coded within an NcoI restriction site at the 59 end, was digested with NcoI
and EcoRI, and ligated into the shuttle vector pGEM7ZAd (a gift of David
Ron, New York University, New York, NY). pGEM7ZAd contains in-
serted into its HindIII–EcoRI sites a unique NcoI site that places the
initiating methionine-encoding codon in the context of an optimal ribo-
somal binding Kozak sequence (Ron and Habener, 1992). The resulting
pGEM7ZAd-C/Nestin was subsequently digested with HindIII and EcoRI,
and the insert was cloned into similarly digested pcDNAI (Invitrogen,
Carlsbad, CA) for the expression of the C-terminal tail of nestin under the
control of the cytomegalovirus promoter.
Generation of anti-nestin antiserum. Bacterial expression of GST-C/
Nestin was induced in exponentially growing Escherichia coli JM109
treated with 0.4 mM isopropyl-b-thiogalactopyranoside for 3 hr. The
recombinant fusion protein was then purified using glutathione-
Sepharose 4B beads (Pharmacia), and it was used subsequently to inoc-
ulate two rabbits following standard protocols. Only one of the resulting
antisera is reported in these studies. Specificity of anti-nestin antiserum
was determined by Western immunoblot (1:20,000 dilution). For immu-
nocytochemistry it was used at 1:10,000 dilution.
Transfections. COS-1 cells were transfected with the DEAE method as
described (Cato et al., 1986), with the exception that plasmid DNA was
left in contact with cells for 3 hr.
Establishment of RC2.E10 cells. Primary cultures of cells from devel-
oping cerebral cortex were prepared from E16 fetuses removed from
timed-pregnant Sprague Dawley rats. Fetuses were placed in PBS for the
dissection of the brain, which was subsequently transferred to HBSS
(Life Technologies). The cerebral cortex was separated on both sides
from the rest of the brain using iridectomy scissors, and the meningeal
membranes were carefully removed. The resulting pieces were incubated
with 0.025% trypsin and dissociated by trituration into a homogeneous
cerebrocortical cell suspension which was pelleted and resuspended in
DMEM supplemented with 10% heat-inactivated fetal bovine serum
(FBS). Cells were seeded on plates previously coated with poly-D-
ornithine (Sigma) at a density of 100,000 cells/cm 2 and cultured at 37°C
in a humidified 5% CO2 incubator. The following day, cells were infected
as described (Renfranz et al., 1991) with a replication-defective recom-
binant retrovirus derived from the Moloney murine leukemia virus that
contains a neomycin resistant gene and a simian virus 40 large-T antigen
(SV40T) oncogene encoding the tsA58/U19 temperature-sensitive mutant
allele (Jat and Sharp, 1989; Almazan and McKay, 1992). Retroviral
particles (titer, 10 5 colony-forming units/ml) were produced by a C-2
packaging fibroblast cell line (F4 subclone; kindly provided by Dr. G.
Almazan, McGill University, Montreal, Quebec, Canada). Conditioned
medium from C-2 fibroblasts was filtered and applied for 2 hr directly
onto primary cultured cells in the presence of 8 mg/ml polybrene (Sig-
ma). Cells were incubated at 33°C in DMEM supplemented with 10%
FBS in the presence of the neomycin analog G418 (Life Technologies).
Resistant colonies appeared 3–5 weeks later and were individually picked
using cloning rings and expanded. After five to six passages, a fraction of
cells from each colony was frozen in liquid nitrogen. A total of 38 cell
lines were established, one of which, named RC2.E10, has been cultured
in our laboratory for .2 years undergoing .60 passages with no appre-
ciable changes in phenotypic features (Schwartz and Vallejo, 1998).
Growth curves, proliferation, and differentiation of RC2.E10 cells. To
determine growth curves, RC2.E10 cells were plated into 60 mm tissue
culture dishes at initial densities of 10 4, 3 3 10 4, or 10 5 cells per dish and
maintained at 33°C in DMEM and 10% FBS for the specified number of
days. On day 0, some plates were incubated for 4 hr after plating to allow
cells to attach to the surface of the dish, after which they were transferred
to a 39°C incubator. Cells in this group of plates were either maintained
in DMEM and 10% FBS or washed and cultured in serum-free DMEM.
At different time points (every 24 hr) cells were trypsinized, collected by
centrifugation, and counted with a hemocytometer. Culture media of the
remaining cells were changed every 2 d.
Proliferation rates of RC2.E10 cells in different culture conditions
were determined by assessing bromodeoxyuridine (BrdU) incorporation
immunocytochemically using an Amersham (Arlington Heights, IL)
RPN 20 cell proliferation kit. Cells growing in 100 mm dishes were
trypsinized and plated in 35 mm dishes at a density of 2 3 10 4 cells/cm 2
and incubated at 33°C in DMEM and 10% FBS for at least 24 hr. After
this time, BrdU (10 mM) was added, and cells were further incubated
overnight (16–18 hr). Cells were fixed in acid and ethanol (90% ethanol
and 5% acetic acid) and processed for immunocytochemistry with a
monoclonal anti-BrdU antibody. Control cells that had not been treated
with BrdU were processed in parallel in an identical manner. Immuno-
detection was performed with a biotinylated horse anti-mouse antiserum
(Bio-Rad, Hercules, CA) using nickel–ammonium-enhanced immuno-
peroxidase staining. Fields of vision were either photographed using a
Zeiss (Thornwood, NY) Axioscope or captured with a Nikon (Tokyo,
Japan) microscope equipped with an Optronics TEC-470 charge-coupled
device camera (Optronics Engineering, Goleta, CA) interfaced with a
PowerMac 7100 computer, and analyzed with IP Lab spectrum analysis
software (Signal Analitics Corp., Vienna, VA). BrdU incorporation was
quantified by determining the percentage of BrdU-labeled cells relative
to the total number of cells per field of vision as observed by phase-
contrast microscopy. Experiments were performed in duplicate, and at
least 10–12 fields of vision per dish were quantified.
For experiments involving incubation at the nonpermissive tempera-
ture, cells were allowed to recover from trypsinization for 6–8 hr at 33°C
in DMEM and 10% FBS. After this, medium was removed from dishes
and replaced by serum-free DMEM containing N1 supplement (Sigma)
and 1 mM sodium pyruvate (defined medium) (Bottenstein and Sato,
1979), to which bFGF (20 ng/ml) was added. At this point, they were
transferred to a different incubator and cultured at 39°C in a humidified
atmosphere containing 5% CO2. BrdU was added 2 d after transferring
the cells to the high-temperature incubator.
For differentiation experiments, RC2.E10 cells were allowed to re-
cover from trypsinization for 4 hr at 33°C in DMEM and 10% FBS and
were subsequently transferred to defined medium containing bFGF (20
ng/ml) and incubated at 39°C for at least 30 hr. Then, 8-bromo-cAMP
(8Br-cAMP; 1 mM) or forskolin (10 mM) was added to the medium, and
incubation proceeded overnight at 39°C, after which cells were fixed and
processed for immunocytochemistry.
Primary cortical cell cultures. The cerebral cortex from fetal brains of
E17 Sprague Dawley rats were dissected as described above, and cell
suspensions were generated by trituration in HBSS without the addition
of trypsin. Cells were pelleted, resuspended in defined medium supple-
mented with bFGF (20 ng/ml), seeded into poly-D-ornithine-coated 10
cm dishes at a density of 2–4 3 10 4 cells/cm 2, and maintained at 37°C.
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Medium was changed every 2 d, and cells were passaged before reaching
confluence (usually 5–6 d after plating) by treatment with 0.025% tryp-
sin, which was inactivated by adding DMEM and 10% FBS. Cells were
then washed, resuspended in defined medium containing bFGF, and
seeded either into 10 cm dishes for expansion (1:3 ratio) or into 35 mm
dishes for differentiation experiments, in which case plating density was
3 3 10 4 cells/cm 2. Cells were not trypsinized more than twice before an
experiment was performed.
For differentiation experiments, cells were incubated at 37°C for at
least 24 hr after plating. At this time, bFGF-containing medium was
replaced with bFGF-free defined medium, and 8Br-cAMP (1 mM) or
forskolin (10 mM) was added. Cells were further incubated for 2 or 5 d,
at the end of which they were processed for immunocytochemistry. For
proliferation studies, BrdU (10 mM) was added to cells either 5 or 16 hr
before they were fixed. BrdU incorporation was detected immunocyto-
chemically, and the proportion of labeled cells was determined as de-
scribed above.
Western immunoblots. E17 rat forebrain or cells growing in 35 mm
dishes were lysed in buffer containing 125 mM Tris-HCl, pH 6.8, 4% SDS,
15% glycerol, 10% b-mercaptoethanol, and 10 mM dithiothreitol. Pro-
teins were resolved by SDS-PAGE and blotted onto a nitrocellulose
membrane. Monoclonal primary antibodies were used to detect SV40T
(1:1000 dilution, clone PAb 416; Calbiochem, La Jolla, CA), and glial
fibrillary acidic protein (GFAP; 1:10,000 dilution, clone G-A-5; Sigma),
followed by incubation with a horse anti-mouse peroxidase-conjugated
secondary antibody (1:5000 dilution; BioRad, Hercules, CA). CREB
immunoreactivity was detected with a rabbit polyclonal primary anti-
serum (1:500 dilution; Santa Cruz Biotechnology, Santa Cruz, CA),
followed by incubation with a goat anti-rabbit peroxidase-conjugated
secondary antibody (1:10,000 dilution) (Bio-Rad). Immunoreactive
bands were visualized using an enhanced chemiluminescence detection
system (Amersham, Buckinghamshire, England).
Immunocytochemistry. Immunocytochemistry was performed with
cells plated into poly-D-ornithine-coated 35 mm tissue culture dishes.
Cells were fixed in 4% paraformaldehyde in PBS for 5 min, washed in
PBS, and permeabilized with methanol for 2 min at 220°C. After
blocking with normal goat serum (for polyclonal antisera) or normal
horse serum (for monoclonal antibodies) for 1 hr, cells were incubated
overnight with the corresponding primary antisera at 4°C. Polyclonal
antisera used were nestin (1:10,000 dilution), calbindin D-28K (1:1000
dilution) (Moratalla et al., 1996), neural cell adhesion molecule (NCAM;
1:500 dilution; Santa Cruz Biotechnology), and galactocerebroside (1:
1000 dilution; Sigma). Monoclonal antibodies for SV40T (1:100 dilution,
clone PAb 416; Calbiochem), MAP-2 (1:300 dilution, clone HM-2;
Sigma), S100b (1:500 dilution, clone SH-B1; Sigma) and GFAP (1:300
dilution, clone G-A-5; Sigma) were used. Immunodetection was per-
formed with secondary biotinylated goat anti-rabbit or horse anti-mouse
antisera (Bio-Rad) using immunoperoxidase staining with a Vectastain
ABC kit (Vector Laboratories, Burlingame, CA).
Two-color dual antigen immunocytochemistry was performed serially,
basically as described (Moratalla et al., 1996). First, BrdU was detected
as described above, using immunoperoxidase staining enhanced with
nickel–ammonium, which yields a dark purplish gray color. Once devel-
oped, cells were washed, and GFAP immunocytochemistry proceeded as
described above, using immunoperoxidase staining without nickel–am-
monium, which yields a brown color.
RT-PCR and Southern blot hybridization. Total RNA (10 mg) purified
from RC2.E10 cells using Triazol (Life Technologies) was primed with
poly(dT)15 and incubated with avian myeloblastosis virus reverse tran-
scriptase (Boehringer Mannheim) to synthesize cDNA. For PCR ampli-
fication of nestin, primers and conditions were identical to those used to
construct pcDNAI-C/Nestin (see above), except that only 27 PCR cycles
were used. After PCR, an aliquot of the reaction was resolved in a 1%
agarose gel, blotted onto a nylon membrane, probed with a 32P-labeled
internal primer (59-ATTCCTGGTCCTCAGGGGAAGAC-39) that corre-
sponds to nucleotides 5520–5542 of the nestin cDNA (Lendahl et al., 1990),
and autoradiographed at 270°C. For PCR amplification of actin, the
primers used were as follows: forward, 59-GACGATATGGAGAAG-
ATTTGGCA-39, which anneals to exon 2; reverse, 59-CCATCTCTTGC-
TCGAAGTCTAGG-39, which anneals to exon 3. The following protocol
was used: 94°C for 5 min, followed by 20 cycles of 94°C for 30 sec, 55°C for
30 sec, and 72°C for 30 sec, after which a 5 min incubation at 72°C
followed. As a probe to detect the PCR product after blotting onto
nitrocellulose, the following 32P-labeled internal primer was used:
59-CACACGCAGCTCATTGTAGAAAGT-39.
RESULTS
Initially, we used embryonic cortex-derived RC2.E10 cells, a
clonally expanded cell line immortalized by expression of a
temperature-sensitive mutant allele of SV40T (Schwartz and
Vallejo, 1998). RC2.E10 cells were routinely propagated at 33°C
in the presence of FBS. Under these conditions, they exhibit a flat,
elongated morphology with relatively large nuclei surrounded by
abundant cytoplasm, with the occasional cell extending short
processes. After reaching confluence, cells become polygonal and
form a compact epithelial monolayer covering the entire surface
of the culture plate, and at this point cell growth is inhibited.
Temperature-dependent inactivation of SV40T in
RC2.E10 cells
It is likely that the presence of the immortalizing SV40T prevents
cells from exiting the cell cycle and inhibits differentiation (Fan-
ning, 1992). Because one purpose of our study was to investigate
the differentiation potential of RC2.E10 cells, we proceeded to
the inactivation of this oncogene by raising the incubation tem-
perature to 39°C. Cells growing at 33°C were found to exhibit
nuclei with abundant SV40T immunoreactivity, as assessed by
immunocytochemistry, using a monoclonal anti-SV40T antibody
(Fig. 1A). When the temperature of incubation was shifted to the
nonpermissive 39°C, SV40T immunoreactivity was significantly
reduced after 8 hr and was undetectable after a 24 hr incubation
(Fig. 1B). In a different set of experiments, Western immunoblot-
ting using the same antibody revealed that degradation of the
SV40T protein proceeded gradually and was maximum by 24 hr
(Fig. 1C).
Growth curve and proliferation of RC2.E10 cells in
different culture conditions
The growth curve of RC2.E10 cells cultured at 33 or 39°C in the
presence or absence of serum was determined by counting cells at
different time intervals after plating. Cells maintained at 33°C in
DMEM and 10% FBS showed continuous growth with an ap-
proximate doubling time of 36 hr (Fig. 2A). When the tempera-
ture of incubation was raised to 39°C 4 hr after plating and
maintained for several days, the number of cells increased for 2–3
d, but after this time no further increase was observed, and a clear
decline occurred after 4–5 d (Fig. 2B). Finally, when cells were
cultured at 39°C in serum-free medium the cell number decreased
gradually, and practically all of them had died 5–6 d after plating
(Fig. 2B). Similar results were obtained in experiments per-
formed with different plating densities, ranging between 104 and
105 cells per dish.
RC2.E10 cell proliferation was also evaluated by determining
the relative number of cells that incorporate BrdU. After an
overnight incubation with BrdU, a relatively large number of cells
(60–70%) were found to incorporate BrdU when cultured at 33°C
in the presence of 10% FBS (Fig. 2). Increasing the temperature
of incubation to 39°C markedly reduced the number of cells that
incorporated BrdU, although a significant number of proliferating
cells remained (Fig. 2). When cells were incubated at 39°C in
defined medium lacking FBS, a significant reduction in the num-
ber of proliferating cells was observed compared with those
grown under the same conditions but in serum-containing me-
dium (Fig. 2). Thus, these data indicate that serum provides
mitogenic factors capable of stimulating proliferation of RC2.E10
cells. However, it appears that the presence of SV40T is required
for long-term survival, and therefore RC2.E10 cells are condi-
tionally immortalized cells. Similar results were obtained in ex-
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periments in which the time of exposure to BrdU was reduced to
2 hr, although the relative percentage of cells labeled was lower
and no labeled cells were observed when incubation was per-
formed at 39°C in the absence of FBS (results not shown).
We investigated whether bFGF is sufficient to stimulate prolif-
eration of RC2.E10 cells in serum-free medium, because this
growth factor has been shown to provide a mitogenic stimulus to
maintain proliferation of cortical neural precursor cells (Ghosh
and Greenberg, 1995). We found that addition of bFGF (20
ng/ml) to RC2.E10 cells maintained at 39°C in defined medium
significantly increased the number of BrdU-labeled cells to levels
that were not significantly different from those observed in the
presence of FBS (Fig. 2).
RC2.E10 cells are neuroepithelial precursors
To further investigate whether RC2.E10 cells exhibit phenotypic
features of neural precursors, we sought to determine whether
they express nestin, a marker of undifferentiated neural precursor
cells (Lendahl et al., 1990). A rabbit anti-nestin antiserum was
raised against the C-terminal region of the protein, and its spec-
ificity was initially tested by Western immunoblot using bacteri-
ally expressed GST-C/Nestin that had been cleaved with throm-
bin (Guan and Dixon, 1991). The antiserum was shown to
recognize both the GST and the truncated nestin fragments (Fig.
3A). The C-terminal region of nestin was also expressed in COS
cells transfected with pcDNAI-C/Nestin and assayed by Western
immunoblot. No signal was detected in control cells transfected
with pcDNAI containing no insert, but a single band of the
expected molecular mass was detected in cells transfected with
pcDNAI-C/Nestin (Fig. 3B). Preincubation of the antiserum with
purified GST did not disturb this band, but it was abolished by
preincubation with purified GST-C/Nestin (Fig. 3B). Finally, to
test whether the antiserum could recognize endogenous nestin,
Western immunoblots were performed using lysates of embryonic
brain dissected from E17 rat fetuses, and a single band with an
apparent molecular mass of ;200 kDa was observed (Fig. 3C). A
similar result was obtained using E15 rat fetuses (result not
shown). This band was not altered when the antiserum was
preincubated with purified GST but was not detectable when the
antiserum was preincubated with GST-C/Nestin (Fig. 3C).
To determine whether RC2.E10 cells express nestin, both
Western immunoblot and immunocytochemistry were per-
formed. By Western immunoblot, lysates of cells growing at 39°C
in the presence of bFGF (20 ng/ml) generated a single immuno-
reactive band of relatively high molecular mass that comigrated
with the one observed in embryonic brain lysates (Fig. 3C). By
immunocytochemistry, cells were found to have immunoreactive
cytoplasm (Fig. 3D). This immunoreactivity was not altered when
the antiserum was preincubated with purified GST but was un-
detectable when antiserum preincubation was performed with
GST-C/Nestin fusion protein (Fig. 3E).
Differentiation of RC2.E10 cells into an astrocyte-like
phenotype by cAMP
For differentiation experiments, cells were incubated at 39°C in
defined medium containing bFGF. The morphology of RC2.E10
cells maintained under these conditions was not appreciably dif-
ferent from those maintained at 33°C in DMEM and 10% FBS.
To explore the possibility that activation of the cAMP signaling
pathway induces differentiative effects, we treated RC2.E10 cells
with 1 mM 8Br-cAMP. Under these conditions, remarkable
changes in cell morphology were observed. Cell bodies became
comparatively small and spherical, and cells started to put out
processes. These changes were initially apparent within 6–8 hr
from the onset of treatment and developed over 12–16 hr (Fig. 4).
A similar response was observed when forskolin (10 mM), a direct
activator of adenylate cyclase, was used (results not shown). In
contrast, no morphological changes were observed when similar
experiments were performed using a different cell line, RH1.C4
(Schwartz and Vallejo, 1998), established from developing rat
hippocampus (results not shown). Changes in morphology in-
duced by 8Br-cAMP were also observed in cells growing at 33°C.
However, under these conditions, the observed changes were
transient, and cells reverted to an undifferentiated morphology
within 24–48 hr, thus indicating that stable differentiation cannot
take place in the presence of the SV40T oncogene. In contrast,
cells incubated at 39°C in defined medium retained the morpho-
logical changes induced by 8Br-cAMP for at least 1 week after
treatment, although survival was poor, and .50% of cells died
during that time.
Because RC2.E10 cells exhibit phenotypic features of neural
precursors (bFGF-dependent proliferation, expression of nestin,
Figure 1. Temperature-dependent expression of the tsA58/U19 SV40
T-antigen. A, B, Immunocytochemistry of RC2.E10 cells grown in
DMEM and 10% FBS either at 33°C ( A) or at 39°C ( B) for 24 hr
performed in parallel with an anti-SV40T monoclonal antibody (1:100
dilution). A, SV40T-immunopositive cell nuclei, detected after culturing
cells at the permissive temperature. B, In contrast, SV40T immunoreac-
tivity is not detected in cells cultured at the nonpermissive temperature,
indicating temperature-dependent degradation of the oncogene. C, West-
ern immunoblot showing time course of the temperature-dependent deg-
radation of the SV40T mutant. All cells were grown in DMEM and 10%
FBS and harvested at the indicated times after increasing the temperature
of incubation to 39°C. Note that a shift from the permissive to the
nonpermissive temperature did not affect immunoreactive levels of
CREB, used as a control. Approximately 5 mg of protein were loaded in
each lane.
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and morphological differentiation), it was of interest to determine
whether the differentiative response to 8Br-cAMP represents a
phenotypic transition involving the acquisition of neuronal or glial
features. For this purpose, cells were cultured at 39°C in defined
medium containing bFGF and were treated with 8Br-cAMP (1
mM) for 16 hr before evaluation. Phenotypic characterization of
RC2.E10 cells was performed immunocytochemically, using mono-
clonal antibodies against well established markers such as the
neuron-specific NCAM, calbindin, and MAP-2 (Matus et al., 1986;
Ghosh and Greenberg, 1995; Johe et al., 1996); the astrocyte-
specific GFAP (Eng, 1985; Gross et al., 1996; Johe et al., 1996;
Bonni et al., 1997; Koblar et al., 1998; Mi and Barres, 1999); S100b,
found predominantly in astrocytes (Hinkle et al., 1998; Mi and
Barres, 1999); and the oligodendrocyte-specific galactocerebroside.
Undifferentiated, nestin-positive RC2.E10 cells did not stain
for neuronal or glial markers (Fig. 4). After treatment with
8Br-cAMP, concomitant with the observed morphological
changes, cells became strongly immunoreactive to GFAP, which
was localized to the cell soma and processes (Fig. 4D). For
quantification, 5–10 fields of vision per dish were examined in
three different dishes from independent experiments, and the
percentage of GFAP-positive cells relative to the total number of
cells was determined to be 84 6 4.7 (mean 6 SEM). RC2.E10
cells also stained immunopositively for S100b after treatment
with 8Br-cAMP (Fig. 4F) (percentage of positive cells, 82 6 2.5).
No staining for MAP-2 (Fig. 4H), NCAM, calbindin, or galacto-
cerebroside (results not shown) was observed in differentiated
cells, indicating the absence of neurons or oligodendrocytes.
Western immunoblotting confirmed the increase in GFAP ex-
pression after treatment with 8Br-cAMP (Fig. 4 I). Immunocyto-
chemistry and RT-PCR and Southern blot analysis revealed that
differentiated RC2.E10 cells express reduced amounts of nestin
(Fig. 5). Thus, these results are consistent with the notion that
RC2.E10 cells acquire an astroglial phenotype after activation of
the cAMP-dependent signaling pathway.
Effects of cAMP stimulation on RC2.E10
cell proliferation
The proliferative effects of growth factors, including bFGF, are
associated with the phosphorylation-dependent activation of the
mitogen-activated protein kinase (MAPK) signaling pathway. In
many cell types, including astrocytes (Kurino et al., 1996), acti-
vation of MAPK is blocked by cAMP, resulting in decreased
proliferation (for review, see Burgering and Bos, 1995). For this
reason, we sought to determine whether the differentiative effects
of 8Br-cAMP on RC2.E10 cells may be related to a blockade of
cell proliferation.
By determining the percentage of cells that incorporate BrdU,
we found that RC2.E10 cell proliferation decreased significantly
when cells cultured in the presence of bFGF were treated with
Figure 2. Growth curves and proliferation
rates of RC2.E10 cells incubated under
different culture conditions. A, B, Growth
curves of RC2.E10 cells incubated at 33°C
in DMEM and 10% FBS (A) or at 39°C in
either DMEM and 10% FBS or serum-free
medium (SFM ) (B). Initial plating density
was 3 3 10 4 cells per dish (60 mm cell
culture dishes were used). Values repre-
sent mean 6 SEM of six (A) or four (B)
independent experiments. Some error bars
are too small to be visible. C–F, Phase-
contrast micrographs of RC2.E10 cells
treated overnight with 10 mM BrdU and
processed immunocytochemically with a
monoclonal anti-BrdU antibody to deter-
mine nuclear incorporation. Culture con-
ditions were as follows: C, 33°C in DMEM
and 10% FBS; D, 39°C in DMEM and 10%
FBS; E, 39°C in serum-free DMEM sup-
plemented with N1 medium and sodium
pyruvate (defined medium); and F, 39°C in
defined medium containing 20 ng/ml basic
fibroblast growth factor. G, Quantification
of the percentage of BrdU-positive cells
per field of vision ( fov). Cells were visual-
ized under light microscopy, and the num-
ber of immunocytochemically stained nu-
clei was counted. The total number of cells
in the same field of vision was subsequently
determined using phase-contrast micros-
copy. Values represent mean 6 SEM of
data gathered from three experiments per-
formed in duplicate. At least 10–12 fov per
dish were examined. DM, Defined medium.
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8Br-cAMP (Fig. 6). Inhibition of MAPK phosphorylation by
8Br-cAMP was monitored by Western immunoblotting, using a
specific antibody (New England Biolabs) that specifically recog-
nizes the phosphorylated Erk-1 and Erk-2 MAPK isoforms (re-
sults not shown). Treatment of RC2.E10 cells with PD98059, a
specific inhibitor of MAPK phosphorylation (Alessi et al., 1995),
resulted in a significant decrease in the number of cells prolifer-
ating in the presence of bFGF, similar to that observed after
treatment with 8Br-cAMP (Fig. 6). However, no morphological
differentiation and no increase in GFAP expression, as assessed
immunocytochemically, were observed in PD98059-treated cells,
indicating that astrocyte differentiation is not simply a result of
blocking cell proliferation.
cAMP stimulation induces astroglial differentiation of
primary cortical precursors
Because of the clonal nature of RC2.E10 cells, it is formally
possible that they may represent a specific nonabundant type of
cortical precursor cell expanded in vitro after immortalization. If
that were the case, their capacity to differentiate in response to
activation of the cAMP-dependent pathway would not be repre-
sentative of whether a large number of neural precursors present
in the developing cortex have the competence to differentiate into
astrocytes after stimulation of this signaling pathway. To address
this question, we performed experiments in primary cultures of
cortical precursors prepared from E17 rats.
Cortical cells maintained in defined medium in the presence of
bFGF were uniformly immunopositive for nestin, indicating that
they are neuroepithelial precursors (Fig. 7D). They exhibited no
immunoreactivity for the lineage-specific markers GFAP (Fig.
7A), MAP-2, NCAM, and galactocerebroside (results not
shown). Withdrawal of bFGF for 2 d did not cause appreciable
cell death and resulted in the appearance of GFAP immunore-
activity in 5–10% of cells (mean 6 SEM, 7.4 6 2.2). In contrast,
when 8Br-cAMP (1 mM) or forskolin (10 mM) was added to the
medium immediately after bFGF withdrawal, the percentage of
GFAP-positive cells rose to 72 6 4.7 after 2 d. GFAP-positive
cells exhibited morphological features typical of astrocytes, ex-
tending relatively short processes (,20 mm in most cells) and
acquiring a stellate morphology (Fig. 7B). The increase in GFAP
expression after 8Br-cAMP treatment was confirmed by Western
Figure 3. Characterization of nestin antiserum and expression of nestin in RC2.E10 cells. A–C, Western immunoblots of the following: A, GST-C/nestin
fusion protein, either intact or cleaved with thrombin, and control GST, expressed in E. coli and purified on glutathione-Sepharose beads; B, lysates of
COS cells transfected with pcDNAI (Vector) or with pcDNAI-C/Nestin (C/Nestin); and C, lysates of developing forebrain dissected from E17 rat
embryos (E17 Brain) or of RC2.E10 cells. For cell lysates, ;5 mg of protein were loaded in each lane. When indicated, nestin antiserum (1:20,000
dilution) was preincubated with purified GST or GST-C/Nestin recombinant proteins (60 ng/ml each). D, Immunocytochemical detection of nestin in
RC2.E10 cells. E, RC2.E10 cells processed for nestin immunocytochemistry using antiserum preincubated with purified GST-C/Nestin fusion protein
(60 ng/ml). Scale bar, 50 mm.
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immunoblotting (Fig. 7G). When cells were left in culture for 5 d
after the addition of 8Br-cAMP, they exhibited intense GFAP
immunostaining, and the processes displayed a more elaborate
morphology and greater length (50–100 mm) than those cultured
for 2 d (Fig. 7C). Cells treated with 8Br-cAMP did not express
MAP-2, NCAM, or galactocerebroside (results not shown), sug-
gesting that activation of the cAMP-dependent pathway in neural
precursors does not promote neuronal or oligodendroglial
differentiation.
Inhibition of nestin expression has been associated with termi-
nal differentiation of neural cells. However, it has been reported
that at least some astrocytes can express both nestin and GFAP
(Johe et al., 1996; Bonni et al., 1997; Rajan and McKay, 1998). To
investigate whether exposure to cAMP has any effect on nestin
expression in primary cortical precursors, we performed immu-
nocytochemistry on cells treated with 8Br-cAMP for 2 or 5 d.
Nestin immunoreactivity was less intense 2 d after treatment,
relative to control untreated cells, and decreased even further 5 d
after treatment (Fig. 7D–F). Thus, expression of nestin was
reduced in a time-dependent manner and, in general, cells that
displayed a more elaborate, differentiated morphology were less
immunoreactive for nestin (Fig. 7F).
Figure 4. Astroglial differentiation of RC2.E10 cells induced by treatment with 8Br-cAMP. Cells were cultured at 39°C in defined medium in the
presence of bFGF (20 ng/ml) and were left untreated (A, C, E, G) or treated with 8Br-cAMP (1 mM) overnight (B, D, F, H ). A, B, Phase-contrast
micrographs taken at high magnification. At lower magnification, immunostainings for GFAP (C, D), S100b (E, F ), or MAP-2 (G, H ) are shown. Scale
bar, 50 mm. I, Western immunoblot showing increase in GFAP induced by 8Br-cAMP. Lysates were prepared from cells growing at 39°C in defined
medium containing bFGF (20 ng/ml) and left untreated (2) or from cells cultured in the same conditions but treated with 8Br-cAMP (1 mM) overnight
(1). CREB immunoreactivity was used as a control to ensure that similar amounts of protein were loaded in each lane. Approximately 5 mg of protein
were loaded in each lane.
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Cell proliferation and astrocyte differentiation
Consistent with results obtained with RC2.E10 cells, treatment of
primary cortical precursors growing in the presence of bFGF with
8Br-cAMP resulted in the rapid and long-lasting inhibition of
Erk-1 and Erk-2 phosphorylation (results not shown). We deter-
mined that, in the presence of bFGF, .70% of primary cortical
precursor cells incorporate BrdU after a 5 hr labeling time
(mean 6 SEM, 72 6 5.5). To investigate whether activation of the
cAMP signaling pathway has an effect on cellular proliferation of
cortical precursors, we determined the relative number of cells
that incorporate BrdU after exposure to 8Br-cAMP. For this
purpose, cells were treated after withdrawal of bFGF with 8Br-
cAMP for 2 d and received a pulse of BrdU 5 hr before harvest-
ing. As shown in Figure 8A, exposure of primary cultured cortical
cells to 8Br-cAMP did not increase BrdU incorporation relative
to control cells. Similar results were obtained when BrdU labeling
was performed overnight (results not shown). Thus, cAMP stim-
ulation does not induce proliferation of cortical precursors.
In addition, we performed dual-antigen immunocytochemistry
with BrdU and GFAP antibodies to determine whether cAMP
stimulation may result in the stimulation of proliferation of a
small subset of GFAP-positive astrocyte precursors. We found
that the vast majority of cells that stained for BrdU did not stain
for GFAP, and the vast majority of astrocytes did not stain for
BrdU (Fig. 8B). The number of cells that stained for both BrdU
and GFAP accounted for ,1%. Taken together, these experi-
ments suggest that 8Br-cAMP is not acting on a small proportion
of cortical precursors or specifically stimulating the proliferation
of cells of the astrocyte lineage. Thus, activation of the cAMP-
dependent signaling pathway appears to induce differentiation of
cortical precursors along the astrocyte lineage.
DISCUSSION
cAMP stimulation provides an additional route to
astrocyte differentiation
Two major signal transduction pathways have been implicated so
far in the generation of astrocytes in the CNS. One is the
JAK-STAT signaling pathway that activates GFAP gene expres-
sion in response to CNTF (Johe et al., 1996; Bonni et al., 1997;
Koblar et al., 1998; Rajan and McKay, 1998). The other signaling
pathway is activated by members of the bone morphogenetic
proteins (Gross et al., 1996) and most likely involves activation of
Smad proteins (Ebendal et al., 1998; Zhang et al., 1998). Our
results suggest that the cAMP-dependent signaling pathway may
represent an additional or alternative mechanism to promote
astrocyte differentiation.
An increase in intracellular levels of cAMP activates different
signaling pathways (Vossler et al., 1997; Kawasaki et al., 1998),
the best known of which leads to activation of PKA and phos-
phorylation of CREB and CREB-related transcription factors
(Montminy, 1997). The notion that CREB may participate in the
observed astrocytic differentiation response is supported by our
finding that treatment of RC2.E10 cells or primary cortical pre-
cursors with 8Br-cAMP or forskolin results in the rapid but
Figure 5. Decrease of nestin gene expression after treatment of RC2.E10
cells with 8Br-cAMP. A, B, Nestin immunostaining of RC2.E10 cells
cultured at 39°C in defined medium in the presence of bFGF (20 ng/ml)
before ( A) or after ( B) an overnight treatment with 1 mM 8Br-cAMP.
Scale bar, 50 mm. C, RT-PCR and Southern blot hybridization analysis of
nestin transcripts from RC2.E10 cells that received either no treatment
(NT ) or 8Br-cAMP (1 mM) for the indicated times before harvesting.
Figure 6. Inhibition of RC2.E10 cell proliferation by 8Br-cAMP. Cells
were cultured at 39°C in the presence of bFGF (20 ng/ml). Either
8Br-cAMP (1 mM) or the inhibitor PD98059 (20 mM) was added concom-
itantly with BrdU (10 mM) 16 hr before harvesting. Quantification of the
percentage of BrdU-positive cells per field of vision ( fov) is represented.
Values are mean 6 SEM of data gathered from three experiments
performed in duplicate. At least 10–12 fov per dish were examined.
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transient phosphorylation of CREB, being evident within 5 min
and lasting for ;30 min (M. F. McManus, L.-C. Chen, and I.
Vallejo, unpublished observations). However, treatment of
RC2.E10 cells or primary cortical precursors with serum, bFGF,
or glutamate, agents that did not induce astrocyte differentiation,
resulted in rapid but long-lasting (.4 hr) phosphorylation of
CREB; therefore CREB phosphorylation per se does not appear
to be sufficient to promote astrocyte differentiation.
An association between cAMP production and the develop-
ment or maintenance of a neuronal or glial phenotype has been
observed both in the peripheral and central nervous systems.
Thus, elevated intracellular levels of cAMP appear to be impor-
tant for Schwann cell differentiation (Stemple and Anderson,
1992) and for survival of spinal motor neurons (Hanson et al.,
1998) or astrocyte precursor cells from the optic nerve (Mi and
Barres, 1999). In addition, cAMP has been previously shown to
stimulate GFAP gene expression (Kaneko et al., 1994; Segovia et
al., 1994) and to alter the morphology of astrocytes (Shain et al.,
1987; Goldman and Abramson, 1990; Imamura and Ozawa,
1998). Our results now suggest that cAMP acts in undifferentiated
neural precursors to induce a phenotypic transition that results in
the generation of astrocytes.
Multipotential neural precursors can undergo phenotypic tran-
sitions when exposed to single factors (Johe et al., 1996). Thus, it
follows that the activation of specific intracellular signaling path-
ways appear to be sufficient to trigger differentiation, possibly by
implementing changes in the expression of specific sets of genes
via activation of appropriate transcriptional mechanisms. That
activation of the cAMP-dependent signaling pathway triggers
astrocyte differentiation implies the possible existence of ligands
in the developing CNS, such as monoamines and neuropeptides,
that promote gliogenesis by acting on G protein-coupled recep-
tors signaling via cAMP production. Receptors for the mono-
amine neurotransmitters serotonin, noradrenaline, and dopamine
are expressed in neural precursors in the developing brain, and
their ligands, present in axons that originate in the brainstem and
midbrain, reach the developing cerebral cortex before the onset of
gliogenesis. An increasing amount of data indicates that some of
these monoamines have effects on cortical development, and thus
they may have trophic functions before acquiring their known
role as neurotransmitters (Lauder, 1993; Lavdas et al., 1997;
Levitt et al., 1997; Naqui et al., 1999). In concert with this notion,
we found that monoamines induce the phosphorylation of CREB
in primary cultures of E17 cortical precursor cells (L.-C. Chen
Figure 7. Astroglial differentiation of primary cortical precursor cells
induced by cAMP stimulation. Cells were cultured in defined medium in
the presence of bFGF (20 ng/ml) and processed for immunostaining of
GFAP ( A) or nestin ( D). After withdrawal of bFGF, cells were treated
with 8Br-cAMP (1 mM) for either 2 d (B, E) or 5 d (C, F ), after which they
were fixed and processed for immunocytochemistry for GFAP (B, C) or
nestin (E, F ). Note that in F, cells with more elaborate morphology
exhibit less intense nestin immunostaining. Scale bar, 50 mm. G, Western
immunoblot showing increase in GFAP induced by 8Br-cAMP. Lysates
were prepared from cells growing in defined medium containing bFGF
(20 ng/ml) (lane 1) or from cells that had been withdrawn from bFGF and
left untreated for 2 d (lane 2) or treated with 8Br-cAMP (1 mM) for 2 d
(lane 3). CREB immunoreactivity was used as a control to ensure that
similar amounts of protein were loaded in each lane. Approximately 5 mg
of protein were loaded in each lane.
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and I. Vallejo, unpublished observations). In addition, neuropep-
tides such as somatostatin, vasoactive intestinal peptide, sub-
stance P, and enkephalins are present in small cortical interneu-
rons before the onset of gliogenesis, and a role for some of them
in neural development has been suggested (Cameron et al., 1998).
Whether monoamines or neuroactive peptides act directly on
undifferentiated cortical precursor cells during development to
promote the differentiation of astrocytes merits further
investigation.
RC2.E10 cells as a model for cortical
astrocyte differentiation
RC2.E10 cells were derived from the embryonic cerebral cortex
at a time during development (E16) at which this structure is rich
in actively proliferating neural precursor cells (Altman and Bayer,
1991; Ghosh and Greenberg, 1995). Many SV40T-immortalized
neural cells retain their capacity to differentiate once the immor-
talizing oncogene has been inactivated (Frederiksen et al., 1988;
Whittemore and White, 1993; Eaton et al., 1995; Rozental et al.,
1995; Martı´nez-Serrano and Bjo¨rklund, 1997; Qi et al., 1997). We
show that, after degradation of the SV40T, RC2.E10 cells differ-
entiate after activation of the cAMP-dependent signaling path-
way to acquire an astrocyte-like phenotype and thus recapitulate
phenotypic properties of neural precursor cells that can differen-
tiate in vitro in response to specific stimuli. We did observe,
however, one important difference between differentiated
RC2.E10 cells and astrocytes generated from primary cortical
precursors. In contrast to primary cells used in this study,
RC2.E10 cell survival after treatment with 8Br-cAMP for several
days was poor. This difference may simply be attributable to their
clonal origin, although phenotypic alterations resulting from the
immortalization process cannot be ruled out.
One key feature of RC2.E10 cells is that they retain phenotypic
features of neural precursors. These include (1) expression of
nestin, (2) requirement of bFGF for proliferation, (3) stimulus-
dependent morphological differentiation and stimulation of
GFAP expression, and (4) decrease in nestin expression concom-
itant with the acquisition of a differentiated phenotype. In addi-
tion, neuroepithelial cells present in the developing CNS main-
tain the expression of region-specific homeodomain transcription
factors likely to control cell autonomous mechanisms of differen-
tiation even after dispersion and immortalization in vitro (Naka-
gawa et al., 1996). In agreement with this notion, we found that
RC2.E10 cells express the homeodomain genes Otx-1, Otx-2,
Dlx-1, and Dlx-2 (data not shown), which encode transcription
factors that participate in forebrain development (Acampora et
al., 1995, 1996; Anderson et al., 1997). Of note, RC2.E10 cells do
not undergo spontaneous differentiation when the immortalizing
oncogene is inactivated. Instead, activation of the intracellular
cAMP signal transduction pathway is necessary to trigger the
differentiative response. This observation further suggests that in
the developing mammalian cortex a subset of progenitor cells may
respond to ligands that signal via cAMP to initiate astrocyte
differentiation.
Precursor cell proliferation and
astrocyte differentiation
An inhibitory effect of cAMP on activation of MAPK has been
described in various cell types, including astrocytes (Burgering
and Bos, 1995; Kurino et al., 1996). This inhibitory effect appears
to be secondary to PKA-dependent phosphorylation of Raf-1,
thus preventing the activation of MAPK (Burgering and Bos,
1995; Kurino et al., 1996). We observed a decrease in the levels of
phosphorylated MAPK in neural precursors that differentiate
into astrocytes in response to cAMP stimulation. However, it is
unlikely that inhibition of MAPK phosphorylation is sufficient for
initiating the differentiation response, because we did not observe
differentiative changes in cells that were treated with PD98059.
Therefore, cAMP stimulation may act as a gating mechanism
(Iyengar, 1996) to synchronize the exit from the cell cycle, by
inhibiting MAPK-dependent proliferation, with the onset of the
differentiation response. Our double-antigen immunocytochemi-
cal studies on primary cortical cells support this notion, because
we found that the vast majority of differentiated astrocytes were
postmitotic and did not incorporate BrdU.
Our study supports the notion that the effect of cAMP stimu-
lation is instructive on the promotion of astrocyte differentiation
from undifferentiated cortical precursors, rather than selective on
survival of astrocytes. This conclusion is supported by the follow-
Figure 8. cAMP stimulation does not induce proliferation of astrocytes.
A, Percentages of primary cortical cells that incorporate BrdU per field of
vision ( fov). Cells were grown in defined medium without treatment
(Control ) or in the presence 8Br-cAMP (1 mM) for 2 d. BrdU (10 mM) was
added 5 hr before fixation and subsequent immunostaining with an
anti-BrdU antibody. Quantification of BrdU-positive cells was performed
as described in Materials and Methods and in the legend to Figure 2G. B,
Dual-antigen BrdU–GFAP immunostaining of primary cortical cells
treated for 2 d with 8Br-cAMP (1 mM), to which a pulse of BrdU (10 mM)
was added for 5 hr before harvesting. Note that BrdU staining is confined
to cells that do not stain for GFAP. Representative examples of BrdU-
immunostained nuclei and GFAP-positive cells are indicated by arrow-
heads and arrows, respectively. Scale bar, 25 mm.
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ing observations: (1) practically all primary cells maintained in
the presence of bFGF stained strongly and uniformly for nestin,
but not for glial or neuronal markers, and incorporated BrdU
actively, indicating that they are proliferating neuroepithelial
precursors; (2) withdrawal of bFGF did not result in cell death;
(3) after bFGF withdrawal and cAMP stimulation, 70–80% of
cells turned GFAP-positive, indicating the occurrence of an in-
structive phenotypic transition; and (4) BrdU incorporation after
bFGF withdrawal did not increase in response to of 8Br-cAMP.
The latter is important because if cAMP stimulation acted on the
selective survival of a small number of preexisting astrocytes,
rather than on differentiation of precursors, the dramatic increase
observed in the number of GFAP-positive cells would imply the
occurrence of a significant proliferative activity of astrocytes
after withdrawal of bFGF and treatment with 8Br-cAMP. Our
BrdU incorporation data indicate that this is not the case, because
withdrawal of bFGF resulted in decreased proliferation, and
8Br-cAMP did not increase BrdU incorporation relative to un-
treated cells. In addition, dual antigen immunocytochemical stud-
ies clearly indicated that GFAP-expressing cells do not
proliferate.
Our findings add to the complexity of mechanisms that are
probably required to integrate a wide variety of signals acting
coordinately in a time- and space-dependent manner to generate
astrocytes in the developing brain. Thus, identification of ligands
that promote gliogenesis by increasing intracellular levels of
cAMP and elucidation of the intracellular events that follow
cAMP stimulation in neural precursors should increase our un-
derstanding of the mechanisms that lead to the restriction of the
developmental fate of developing cells along an astrocyte
phenotype.
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